Abstract
Introduction and hypothesis
A terminology and standardized classification has yet to be developed for those complications related to native tissue female pelvic floor surgery.
Methods
This report on the terminology and classification combines the input of members of the Standardization and Terminology Committees of two International Organizations, the International Urogynecological Association (IUGA) and the International Continence Society (ICS) and a Joint IUGA/ICS Working Group on Complications Terminology, assisted at intervals by many external referees. A process of rounds of internal and external review took place with decision making by collective opinion (consensus).
Results
A terminology and classification of complications related to native tissue female pelvic floor surgery has been developed, with the classification based on category (C), time (T), and site (S) classes and divisions that should encompass all conceivable scenarios for describing operative complications and healing abnormalities. The CTS code for each complication, involving three (or four) letters and three numerals, is likely to be very suitable for any surgical audit or registry, particularly one that is procedure-specific. Users of the classification have been assisted by case examples, colour charts and online aids (www.icsoffice.org/ntcomplication).
Conclusions
A consensus-based terminology and classification report for complications in native tissue female pelvic floor surgery has been produced. It is aimed at being a significant aid to clinical practice and particularly to research.
Similar content being viewed by others
References
Haylen BT, Freeman RM, Swift SE, Cosson M, Davila GW, Deprest J, Dwyer PL, Fatton B, Kocjancic E, Lee J, Maher C, Petri E, Rizk DE, Sand PK, Schaer GN, Webb RJ (2011) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) and grafts in female pelvic floor surgery. Int Urogynecol J 22:3–15, and Neurourol Urodyn 30: 5–15
Stedman’s Medical Dictionary (2006) Lippincott, Williams and Wilkins. Baltimore. U.S.A.
Concise Oxford Dictionary (1995) Clarendon Press. Oxford
Amid P (1997) Classification of biomaterials and their relative complications in an abdominal wall hernia surgery. Hernia 1:15–21
Rosch R, Junge K, Hölzl F et al (2004) How to construct a mesh. In: Schumpelick V, Nyhus LM (eds) Meshes: benefits and risks. Springer, Berlin, pp 179–184
Deprest J, Zheng F, Konstantinovic M et al (2006) The biology behind fascial defects and the use of implants in pelvic organ prolapse repair. Int Urogynecol J 17:S16–S25
Schmid C, O’Rouke P, Maher C (2011) Vaginal invagination. Int Urogynecol J Pelvic Floor Dysfunct 22(Suppl 1):S53–S54. doi:10.1007/s00192-011-1434-z, 22
Haylen BT, De Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for pelvic floor dysfunction. Int Urogynecol J 21:5–26, and Neurourol Urodyn 29:4–20
Acknowledgements
The co-authors acknowledge the support and goodwill of the IUGA and ICS leadership in this third Joint Report from the two Societies, following on from the Joint Reports on (1) Terminology for Female Pelvic Floor Dysfunction [8] and (2) Prostheses and Graft Complications [1]. We thank Mr. Dominic Turner and Mr. Ashley Brookes from the ICS Office for their assistance and expertise in developing the online aids to the previous document [1] and, to a lesser degree, the current document. Dr. Paul Moran from the British Society of Urogynaecology has also assisted in the progress towards an ICS-IUGA Registry of Prosthesis and Graft Complications.
This document has involved five rounds of full review by co-authors and website publication. The comments of the following external referees are gratefully acknowledged: Professor Linda Cardozo, Professor Mary Fitzgerald, Professor Elisabeth Constantini, Professor Peter Dietz, Professor Gamal Ghoniem, Professor Biagio Adile, Dr. Andri Nieuwoudt, Dr. Luis Abranches, Dr. Jia Wen, Dr. Giuseppe Di Paola, Dr. Antoine van Vijfeijken, Dr. Pail de Flamingh, Mr. P Jamjute, Mr. Declan Keane, Dr. Ahmed el Ghiaty, Dr. Joseph Gauta, Dr. Annette Holden.
Additional case examples and photos from Professor Peter Petros, Dr. Anna Rosamilia, Professor Judith Gow, Dr. Hanna Krause and Dr. Ian Tucker have been greatly appreciated.
Conflicts of interest
BT Haylen: No disclosures
RM Freeman: Educational meetings: Astellas and Pfizer. All income from commercial trials and some of the honoraria go to his research fund. Locality lead for the NIHR Peninsula Collaboration for Leadership in Applied Health Research and Care (PenCLAHRC). PROSPECT: A grant holder for this nationally funded trial of prolapse surgery.
J Lee: AMS: Acceptance of paid travel expenses or honoraria. AMS: Acceptance of payment for research (AMS external research grant).
SE Swift: Pfizer: Acceptance of paid travel expenses or honoraria; Acceptance of payment for research. Astellas: Consultant.
M Cosson: Ethicon: Acceptance of paid travel expenses or honoraria; Acceptance of payment for research; Consultant. AMS: Acceptance of paid travel expenses and honoraria; Acceptance of payment for research; Consultant.
J Deprest: AMS: Acceptance of paid travel expenses or honoraria; Acceptance of payment for research; Consultant. Bard: Acceptance of paid travel expenses or honoraria; Consultant. Ethicon (J and J): Acceptance of paid travel expenses or honoraria; Acceptance of payment for research; Consultant. Dynamesh: Acceptance of payment for research.
PL Dwyer: Department research grant from American Medical Systems (AMS).
B Fatton: Astellas: Consultant. Coloplast: Acceptance of payment for research. Ethicon (J and J): Acceptance of paid travel expenses or honoraria. Novartis: Consultant.
E Kocjancic: Coloplast: Consultant. Bard: Acceptance of paid travel expenses or honoraria. AMS: Shareholder. Astellas: Consultant. Pfizer: Acceptance of paid travel expenses or honoraria.
C Maher: Director, Urogynaecology Society of Australasia
E Petri: No disclosures.
DE Rizk: No disclosures.
GN Schaer: Astellas: Holding a position of influence in another professional society/association. Pfizer: Holding a position of influence in another professional society/association. Gynecare (Ethicon): Holding a position of influence in another professional society/association. Novartis: Holding a position of influence in another professional society/association
R Webb: Travel bursaries or honoraria: Pfizer or Astellas. Lecture fees: (departmental) Pfizer, Astellas. Research: Allergan Astellas.
Author information
Authors and Affiliations
Corresponding author
Additional information
International Urogynecology Journal, Vol. 23, No. 5, 2012. Copyright 2012. This material is reproduced with permission of Wiley-Liss, Inc., a subsidiary of John Wiley & Sons, Inc., and the International Urogynecological Association.
This document is being published simultaneously in Neurourology and Urodynamics (NAU) and the International Urogynecology Journal (IUJ), the respective journals of the sponsoring organizations, the International Continence Society (ICS) and the International Urogynecological Association (IUGA) in the closest issue of each journal to the end of April, 2012.
Standardization and Terminology Committee (IUGA)—Bernard T. Haylen, Robert M. Freeman, Joseph Lee, Steven E. Swift, Peter L. Dwyer, Eckhard Petri, Diaa E. Rizk, Gabriel N. Schaer
Standardization Steering Committee (ICS)—Robert M Freeman, Ralph J. Webb
Joint IUGA/ICS Working Group on Complications Terminology - Bernard T. Haylen, Robert M. Freeman, Steven E. Swift, Michel Cosson, Chris Maher, Jan Deprest, Peter L. Dwyer, Brigitte Fatton, Ralph J. Webb
Rights and permissions
About this article
Cite this article
Haylen, B.T., Freeman, R.M., Lee, J. et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint terminology and classification of the complications related to native tissue female pelvic floor surgery. Int Urogynecol J 23, 515–526 (2012). https://doi.org/10.1007/s00192-011-1659-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-011-1659-x